Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PSTV Relative to the S&P 500

PSTV Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Plus Therapeutics Inc. (NASD:PSTV) seasonal charts above shows that a Buy Date of December 22 and a Sell Date of March 31 has resulted in a geometric average return of 1.28% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 101.28% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

To download PSTV seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PSTV